Watchlist Price Alert

UroGen Pharma Ltd. (URGN)

NASDAQ: URGN · Real-Time Price · USD

14.35

2.32 (19.29%)

At close: Jun 16, 2025, 3:59 PM

14.30

-0.35%

Pre-market: Jun 17, 2025, 05:46 AM EDT

UroGen Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	90.4M	82.71M	64.36M	48.04M	11.8M	18K	1.13M	8.16M	17.53M
Cost of Revenue	8.88M	9.36M	7.65M	5.16M	1.01M	n/a	1.8M	600K	28K
Gross Profit	81.52M	73.35M	56.7M	42.88M	10.79M	18K	-675K	7.56M	17.5M
Operating Income	-96.78M	-65.54M	-79.04M	-92.29M	-126.74M	-109.48M	-77.18M	-19.95M	798K
Interest Income	8.9M	2.64M	1.01M	212K	1.63M	4.62M	1.87M	n/a	1K
Pretax Income	-124.04M	-98.32M	-108.03M	-109.37M	-125.11M	-105.15M	-75.53M	-19.98M	-1.94M
Net Income	-126.87M	-102.24M	-109.16M	-110.82M	-128.48M	-100.53M	-75.66M	-20M	-1.94M
Selling & General & Admin	121.15M	93.27M	82.84M	87.53M	90.22M	60.2M	39.57M	8.81M	6.42M
Research & Development	57.15M	45.61M	52.91M	47.64M	47.31M	49.3M	36.93M	18.7M	10.29M
Other Expenses	n/a	n/a	72K	n/a	n/a	-284K	n/a	n/a	n/a
Operating Expenses	178.3M	138.89M	135.74M	135.18M	137.53M	109.5M	76.5M	27.51M	16.7M
Interest Expense	12.52M	14.71M	8.44M	17.44M	357K	284K	n/a	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	187.18M	148.25M	143.4M	140.33M	138.54M	109.5M	78.31M	28.11M	16.73M
Income Tax Expense	2.83M	3.92M	1.14M	1.45M	3.37M	-4.62M	125K	19K	n/a
Shares Outstanding (Basic)	42.88M	28.83M	22.81M	22.35M	21.78M	20.53M	15.75M	9.72M	11.97M
Shares Outstanding (Diluted)	42.88M	28.83M	22.81M	22.35M	21.78M	20.53M	15.75M	9.72M	11.97M
EPS (Basic)	-2.96	-3.55	-4.79	-4.96	-5.9	-4.9	-4.8	-2.06	-0.16
EPS (Diluted)	-2.96	-3.55	-4.79	-4.96	-5.9	-4.9	-4.8	-2.06	-0.16
EBITDA	-110.33M	-63.83M	-78.03M	-90.15M	-122.71M	-108.15M	-77.18M	-19.74M	1.01M
EBIT	-111.52M	-62.06M	-78.03M	-91.93M	-124.75M	-109.48M	-77.18M	-19.95M	798K
Depreciation & Amortization	1.19M	1.71M	1.82M	1.77M	2.04M	1.32M	417K	207K	213K